Replies to post #117403 on Biotech Values

[DewDiligence]

TEVA/MNTA—You still have one more day before you're off the hook DD! :)

I’m not especially worried insofar as I highly doubt that Teva has even submitted its response to the FDA’s deficiency letter.

The more pertinent question, IMO, is whether Teva intends to submit a response at all.

Now that Teva can no longer get any mileage out of hyping its Lovenox program to the investment community (thanks to NVS/MNTA’s lawsuit), Teva might reason that there is more downside than upside in responding to the FDA and thereby exposing Teva to additional avenues of legal discovery in the patent-infringement case.

As PGS noted a while ago… enox-o-what?